|
|||
2007-09-18 15:30:00 CEST 2007-09-18 15:30:00 CEST REGULATED INFORMATION Biohit Oyj - Company AnnouncementBIOHIT BEGINS TEST MARKETING OF ITS XYLICYST CHEWING GUMBiohit Oyj has begun to test market the XyliCyst chewing gum, a functional food product, through an online shop (www.verkkoapteekki.fi). At this stage, it is difficult to estimate the impact of this test marketing on the total net sales of the Biohit Group in 2007. Verkkoapteekki.fi is a Finnish online shop selling health care products and articles via Internet. The XyliCyst chewing gum eliminates acetaldehyde that dissolves in saliva during tobacco smoking. Research studies have shown that acetaldehyde is a major risk factor for cancers of the upper gastrointestinal tract and that it may increase addiction to tobacco products. XyliCyst is developed and marketed by Biohit and manufactured by Fennobon Oy. Biohit Oyj Osmo Suovaniemi President & CEO Further information: Osmo Suovaniemi, M.D., Ph.D., Professor President & CEO Tel: +358-9-773 861 Mobile: +358-40-745 5605 Email: osmo.suovaniemi@biohit.com Distribution: Helsinki Exchanges Financial Supervisory Authority Press http://www.biohit.com |
|||
|